Chemodex

N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine

CHF 95.00
In stock
CDX-T0044-M100100 mgCHF 95.00
CDX-T0044-G0011 gCHF 611.00
More Information
Product Details
Synonyms TPEN; TPEDA
Product Type Chemical
Properties
Formula

C26H28N6

MW 424.5
CAS 16858-02-9
Source/Host Chemicals Synthetic.
Purity Chemicals ≥95% (NMR)
Appearance White to off-white powder.
Solubility Soluble in chloroform or ethanol (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key CVRXLMUYFMERMJ-UHFFFAOYSA-N
Smiles N(CC1=CC=CC=N1)(CC2=CC=CC=N2)CCN(CC3=NC=CC=C3)CC4=CC=CC=N4
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

TPEN is a cell permeable metal ion chelator. TPEN is a chelator that has a high affinity for zinc (Zn2+), next to other transition metals (Zn2+ >Fe2+ >Mn2+) and is used in zinc treatment studies to limit intra- and extracellular concentrations of the mineral. TPEN has lower affinity for Ca2+ and Mg2+ and can also form complexes with other soft metal ions such as Cd2+. In addition to a heavy metal chelator, TPEN is also known to be an apoptosis inducer. Depletion of zinc by TPEN induces apoptosis in several cell lines. TPEN shows anticancer activity through induction of caspase-dependent apoptosis, via reactive oxygen species (ROS) signaling mechanism and inhibiting cell autophagy. TPEN also inhibits RNA binding protein Lin28 and has been shown to be useful in extracting Aβ depostis from Alzheimer's disease brain tissue.

Product References

(1) F. Chimienti, et al.; Biochem. Pharmacol. 6, 51 (2001) | (2) J. Fonte, et al.; J. Alzheimer’s Dis. 3, 209 (2001) | (3) Y.E. Cho, et al.; Nutr. Res. Pract. 1, 29 (2007) | (4) U. Rana, et al.; J. Inorg. Biochem. 102, 489 (2008) | (5) P. Makhov, et al.; Cell Death Diff. 15, 1745 (2008) | (6) P.J. Bernal, et al.; Circul. Res. 102, 1575 (2008) | (7) C.M. Matias, et al.; J. Fluoresc. 20, 377 (2010) | (8) A.J. Morgan, et al.; Cell Calcium. 52, 481 (2012) | (9) O.N. Rahal, et al.; Cancer Biol. Ther. 17, 1139 (2016) | (10) F. Zhang, et al.; Cell Mol. Neurobiol. 37, 235 (2017) | (11) L. Wang, et al.; Cell Rep. 23, 3091 (2018) | (12) V. Soto-Mercado, et al.; Anticancer Agents Med. Chem. 18, 1617 (2018) | (13) Z. Yu, et al.; J. Cell Physiol. 234, 20648 (2019) | (14) M. Mendivil-Perez, et al.; Biometals 34, 49 (2021)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.